HIPEC is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen after CRS. It is considered standard of care for metastatic appendiceal cancer and peritoneal mesothelioma, and is often performed for primary colon cancer and peritoneal metastases. Additionally, in March 2019, the NCCN guidelines included HIPEC as an accepted option at the time of CRS for patients with stage III epithelial ovarian cancer.

By delivering the heated chemotherapy directly in the abdomen, it thoerectically:

• Allows for higher doses of treatment

• Improves the absorption by cancer cells

• Reduces some chemotherapy side effects

By nature, CRS and HIPEC rely on a collaborative clinical environment. At CTCA® Phoenix, every patient with a peritoneal surface malignancy is attended by a multidisciplinary team, which may include gynecologic oncologists, surgical oncologists, medical oncologists, interventional radiologists, dietitians, pain management specialists and supportive care team members.

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Cancer Treatment Centers of America® (CTCA), Phoenix

CRS & HIPEC expertise

Diego Muilenburg, MD, FACSSurgical Oncologist

Degree: MD – Georgetown University School of Medicine, Washington, DC

Residency: General Surgery – University of California-Davis, Sacramento, CA

Fellowships:

• Research Fellowship – University of California-Davis Cancer Center, Sacramento, CA

• Complex General Surgical Oncology – H Lee Moffitt Cancer Center, Tampa, FL

We are committed to rapidly scheduling appointments, often seeing patients within a week of referral. Additionally, we

will collaborate with you to appropriately and deliberately transition patients back into your care following treatment.Contact us to refer a patient or for additional information.

Please send patient information via fax or encrypted email.

Phone: 623.207.3241 Fax: 623.932.8631Email: AZ-referrals@ctca-hope.com

©2019 IPB

cancercenter.com/physicians